Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06543108
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-03
Brief Title:
Preliminary Study on the Diagnostic Value Comparison of 18F-FAPI-04 PETCT and PETMR in Gastric Cancer
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Preliminary Study on the Diagnostic Value Comparison of 18F-FAPI-04 PETCT and PETMR in Gastric Cancer
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This project aims to comprehensively analyze the diagnostic efficacy of SUVmax SUVean TLG MTV etc in gastric cancer through 18F-FAPI-04 PETCT imaging combined with serum tumor markers and other methods and construct a molecular imaging diagnostic model for gastric cancer Next analyze the diagnostic efficacy of 18F-FAPI-04 PETCT and PETMR multimodal imaging in evaluating SUVmax PETCT-PCI and PETMR-PCI for gastric cancer peritoneal metastasis and construct a molecular imaging diagnostic model for gastric cancer peritoneal metastasis Exploring the clinical value of 18F-FAPI-04 PETCT and PETMR imaging in the diagnosis and staging of gastric cancer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None